Sampled on Tuesday announced the expansion of its Sampled SMART Labs facility into a state-of-the-art, 140,000-square-foot laboratory and biorepository in Piscataway.
Construction is expected to be completed by early 2023.
The multimillion-dollar investment will increase the firm formerly known as Infinity BiologiX & Roylance Pharma’s worldwide biorepository capabilities and enable it to store, manage, analyze, research and transport up to 20 million biosamples.
The expansion will also expand Sampled’s laboratory capabilities, enabling clients to conduct research or launch new health products faster and easier.
The new facility is expected to house over 800 freezers and 230 liquid nitrogen tanks with a secure, access-controlled environment, wireless monitoring and full generator and liquid nitrogen backup.
Sampled SMART Labs have College of American Pathologists and Clinical Laboratory Improvement Amendments certification and adhere to International Society for Biological and Environmental Repositories best practices.
“Sampled’s vision is to make it faster and easier for health innovators to improve human health, and this laboratory expansion will enable us to provide even more support for our customers, with added flexibility of scale, service and cost,” Robin Grimwood, CEO of Sampled, stated. “We’re proud to be headquartered in New Jersey’s life science innovation corridor, and look forward to continuing to grow in such a supportive and talent-rich environment.”
“We are thrilled that Sampled SMART Labs is expanding its industry and deepening its investment in Piscataway,” Brian Wahler, mayor of Piscataway, said. “With our proximity to world-class health care facilities and dynamic medical education at Rutgers University, this new growth in local business is a win for everyone, especially with the availability of more good paying jobs for hard-working residents.”
